The companies – and indeed all stakeholders – realise how essential biobanking is for developing new biomarkers and better treatment for future patients, and for providing opportunities for collaborative research, including academic-industry partnerships that will stimulate the economy.
The BWB Biothèque Wallonie Bruxelles provide a tool supporting scientific research in the biomedical field.
The biobanks exist to supply high-quality anonymized samples and data to registered scientists/researchers.
The pharmaceutical industry needs to engage international scientific and healthcare communities in a more collaborative fashion in order to achieve the goal of improving health outcomes. A critical unmet need is access to cohorts of individuals with well-characterized differences in disease progression and treatment outcomes.